| Current Price | $8.39 | Mkt Cap | $1.6B |
|---|---|---|---|
| Open | $8.16 | P/E Ratio | 0.00 |
| Prev. Close | $8.39 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $7.99 - $8.68 | Volume | 5,858,444 |
| 52-Wk Range | $7.61 - $19.99 | Avg. Daily Vol. | 5,733,102 |
A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.
| Current Price | $8.39 | Mkt Cap | $1.6B |
|---|---|---|---|
| Open | $8.16 | P/E Ratio | 0.00 |
| Prev. Close | $8.39 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $7.99 - $8.68 | Volume | 5,858,444 |
| 52-Wk Range | $7.61 - $19.99 | Avg. Daily Vol. | 5,733,102 |
The best Bull and Bear pitches based on recency and number of recommendations.
Already profitable; growing; good pipeline
As I predicted, BioCryst still had a little life left which allowed me to escape my green thumb and flip turn into a red one. 33% jump today, and all because of this:BioCryst Pharmaceuticals, Inc. today announced that it received a preliminary… More
Read the most recent pitches from players about BCRX.
Recs
VladimirPoutine
(< 20)
Submitted: 2/6/2022 2:45:41 PM :
Start Price:
$14.89
NASDAQ:BCRX Score:
-32.76
Already profitable; growing; good pipeline
Recs
PensionExtender
(20.33)
Submitted: 6/30/2020 5:50:50 PM :
Start Price:
$4.90
NASDAQ:BCRX Score:
+42.13
COVID-19 biotech should continue to grow with oral delivery system of vaccine
Recs
mdriver78
(62.80)
Submitted: 5/8/2020 1:14:04 PM :
Start Price:
$4.36
NASDAQ:BCRX Score:
+59.53
Expecting positive sales of over $500 on Berotralstat approval. Plus early clinical data supports BCX9930 as oral monotherapy for complement-mediated diseases plus patient dosing underway in galidesivir trial in COVID-19 patients in Brazil. All sounds quite positive and worth a flyer.
Find the members with the highest scoring picks in BCRX.
Chemnerd (39.73) Score: +564.96
The Score Leader is the player with the highest score across all their picks in BCRX.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| cozynite | < 20 | 3/14/2013 |
|
5Y | $1.31 | +542.21% | +156.00% | +386.21 | 0 Comment | |
| KeepYourCoolFool | 97.47 | 7/29/2009 |
|
5Y | $10.58 | -20.48% | +313.21% | +333.69 | 0 Comment | |
| DRASH5 | < 20 | 7/29/2009 |
|
3W | $10.28 | -18.16% | +314.48% | +332.65 | 0 Comment | |
| BASSTRAX | 36.72 | 8/31/2009 |
|
1Y | $12.99 | -35.24% | +295.29% | +330.53 | 0 Comment | |
| MrTwo94 | 90.26 | 11/8/2012 |
|
1Y | $1.37 | +514.08% | +187.17% | +326.91 | 0 Comment | |
| WeathermanGR13 | 97.46 | 8/17/2009 |
|
5Y | $9.88 | -14.85% | +307.85% | +322.70 | 0 Comment | |
| jgrnot | < 20 | 12/4/2012 |
|
5Y | $1.41 | +496.70% | +183.87% | +312.83 | 0 Comment | |
| SpencerHar | < 20 | 8/3/2009 |
|
1Y | $9.10 | -7.55% | +303.64% | +311.19 | 0 Comment | |
| BadB0y4Lyfe | 25.45 | 8/10/2009 |
|
5Y | $9.27 | -9.25% | +300.18% | +309.43 | 0 Comment | |
| MSFOBV1YH | 96.85 | 11/17/2009 |
|
5Y | $11.18 | -24.75% | +261.73% | +286.48 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
